The chronic myeloid leukemia market reached a value of USD 5.7 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2024. Looking forward, IMARC Group expects the top 7 major markets to reach USD 9.2 Billion by 2035, exhibiting a growth rate (CAGR) of 4.47% during 2025-2035.